VERU INC. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- VERU INC. stock issued during period, value, issued for services for the quarter ending 2025-03-31 was $98.02K.
- VERU INC. stock issued during period, value, issued for services for the quarter ending 2023-06-30 was $1.01M.
- VERU INC. stock issued during period, value, issued for services for the quarter ending 2020-06-30 was $680.94K, a 81.09% decline year-over-year.
- VERU INC. stock issued during period, value, issued for services for the quarter ending 2020-03-31 was $1.23M.
- VERU INC. stock issued during period, value, issued for services for fiscal 2025 was $58.81K.
- VERU INC. stock issued during period, value, issued for services for fiscal 2023 was $1.01M.
- VERU INC. stock issued during period, value, issued for services for fiscal 2021 was $107.96M, a 15754.96% increase from fiscal 2020.
- VERU INC. stock issued during period, value, issued for services for fiscal 2020 was $680.94K, a 92.54% decline from fiscal 2019.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2025-09-30 | $58.81K 10-K · filed 2025-12-17 | |
| 2025-03-31 | $98.02K 10-Q · filed 2026-08-10 | |
| 2023-09-30 | $1.01M 10-K/A · filed 2024-04-01 | |
| 2023-06-30 | $1.01M 10-Q/A · filed 2023-11-15 | |
| 2021-09-30 | $107.96M 10-K · filed 2021-12-02 | |
| 2020-09-30 | $680.94K 10-K · filed 2021-12-02 | |
| 2020-06-30 | $680.94K 10-Q · filed 2021-08-12 | |
| 2020-03-31 | $1.23M 10-Q · filed 2020-05-13 | |
| 2019-09-30 | $9.13M 10-K · filed 2020-12-10 | |
| 2019-06-30 | $3.60M 10-Q · filed 2019-08-08 | |
| 2018-09-30 | $347.08K 10-K · filed 2019-12-12 | |
| 2018-06-30 | $2.00M 10-Q · filed 2019-08-08 | |
| 2017-12-31 | $347.08K 10-Q · filed 2019-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |